4-HO-DET Code experiment

Code of Reality Observed
TD

@Tyler Durden

Conducted: 2026-09-14

4-HO-DET 30 mg
Experiment Report
Observations and experiences

For this experiment it was expected that this would produce 4k code based on similar atomic structure that other compounds produce 4k code. Also both 650nm and a 488nm laser were used to view code. This compound was originally discovered/invented by Albert Hoffman. Atomically shares a few traits that LSD does but lacking a lot of its structure. For this experiment 30mg was ingested orally. Not having any experience with this compound I was surprised and disappointed. I was surprised because the visuals had some similarities to that of LSD. Although physically this compound was very taxing. I felt completely drunk the entire time like a high dose of P. Cubensis can produce. It was also producing extreme jaw clenching and some vasoconstriction which gave it an uncomfortable feeling. Mind like to wonder as well akin similarly to that of LSD. duration 6-7hours. I was able to view code on this compound as well. It was not quite that of 4k code level but definitely much more clear then the DMT gold standard. As with all my experiments I have included an attached URL for experiments pics along with an updated Code Compound Scale. https://photos.app.goo.gl/dz9QSNQszhST6bXi9 #TylerDurden "Ad Astra"

AI Analysis
gpt-5.6-luna
86% Confidence

Summary

This single-subject experiment evaluated Code of Reality (COR) visual phenomena after orally ingesting 30 mg of 4-HO-DET, using diffracted laser light as the visual stimulus. The participant reported perceivable code with greater clarity than their stated DMT reference point, but below the experimenter’s 4K-code category; the experience lasted approximately 6–7 hours and included LSD-like visual and cognitive features alongside marked physical discomfort.

Key Findings

  • COR-like visual patterns were observed with 4-HO-DET, indicating that the phenomenon was not limited to DMT in this observation.
  • The reported code clarity was greater than the participant’s informal DMT “gold standard,” but did not reach the expected 4K level. This directly contrasts with the initial expectation based on perceived structural similarities among compounds.
  • Both 650 nm and 488 nm lasers were reportedly used, although the technical-parameters section specifies only a 650 nm laser at 1 mW and 5 m projection distance. The relative contribution of wavelength therefore cannot be determined from the record.
  • The experience included LSD-like visual effects, mental wandering, intoxication-like impairment, jaw clenching, and vasoconstriction. These subjective and physiological effects may have influenced visual attention, comfort, and the ability to inspect the projected patterns.
  • The reported duration was approximately 6–7 hours following oral administration of 30 mg, but no time-resolved measurements of onset, peak intensity, code clarity, or offset were provided.

Patterns Identified

Visual Patterns

  • Code was reportedly visible when viewing the diffracted laser projection, supporting the presence of a reproducible stimulus-linked visual phenomenon in this session.
  • Perceived code clarity was qualitatively ranked as intermediate: clearer than the participant’s DMT reference, but below the experimenter’s 4K-code category.
  • The description reports visual similarities to LSD, but does not specify the code’s morphology, color, spatial organization, motion, symbolic content, persistence, or whether it appeared on multiple surfaces.
  • No direct comparison between the 650 nm and 488 nm conditions is reported, so wavelength-dependent differences in color, contrast, sharpness, or code visibility remain unresolved.

Behavioral Patterns

  • The participant described cognitive wandering similar to LSD, which may have affected sustained attention and systematic visual reporting.
  • Severe jaw clenching, vasoconstriction, and a persistent intoxicated or “drunk” feeling indicate substantial physical and perceptual load during observation.
  • The participant continued to inspect the laser projection despite discomfort, but the account does not indicate whether code visibility changed with posture, attention, eye movements, distance, or repeated viewing.
  • The subjective report suggests that code manifestation and overall psychedelic intensity were not equivalent: notable drug effects occurred without the code reaching the expected maximum clarity category.

Technical Patterns

  • The stated laser configuration was 650 nm, 1 mW, with a 5 m projection distance and a diffraction grating. These parameters provide a starting point for replication.
  • The narrative states that both 650 nm and 488 nm lasers were used, while the technical section lists only the 650 nm setup. This is an important documentation inconsistency.
  • The equipment list contains a duplicated entry for “Laser Pointer,” and does not specify grating type, groove density, beam diameter, incidence angle, surface material, ambient illumination, camera settings, or whether laser power was measured at the output.
  • The experiment appears to rely primarily on retrospective qualitative judgment and comparison with prior sessions. No blinded condition, control condition, standardized rating instrument, or objective image analysis is described.

Scientific Insights

Scientific Significance

The observation broadens the set of compounds reportedly associated with COR-like visual experiences, but a single uncontrolled session cannot establish that 4-HO-DET causes a distinct code phenomenon or that chemical structure predicts code resolution. The result is potentially informative because the participant reported code visibility despite a clarity level below the expected 4K category, suggesting that code presence and code quality may be separable variables. However, interpretation is limited by the absence of objective stimulus controls, standardized visual scoring, dose verification, and independent observers. The reported physical effects are also scientifically relevant because discomfort, jaw clenching, vasoconstriction, and impaired concentration could confound visual-performance assessments and raise safety concerns.

Methodological Notes

Strengths include documentation of dose, approximate duration, laser wavelength, nominal power, projection distance, and comparison with prior compound experiences. Major limitations include the single-participant design, lack of a sober baseline, lack of randomized or blinded laser conditions, incomplete reporting of the 488 nm setup, and reliance on subjective descriptors such as “clear,” “DMT gold standard,” and “4K code.” The linked photographs and updated scale were referenced but not independently evaluated here; image-based conclusions should therefore not be inferred from the written account alone. The report also does not establish whether the observed patterns were specific to the diffracted laser rather than psychedelic visual imagery, optical artifacts, entoptic effects, or interactions among these factors. The attribution of the compound’s discovery or invention to Albert Hofmann is not assessed by this analysis.

Recommendations

Future sessions should use a preregistered protocol with repeated observations across multiple participants and, where ethically and legally appropriate, a sober baseline and matched non-drug control. Test laser wavelength in separate randomized blocks while holding power, beam geometry, diffraction grating, surface, distance, and ambient lighting constant; document the 488 nm power and all optical specifications. Collect time-stamped ratings of code presence, clarity, motion, color, persistence, and controllability at baseline, onset, peak, and offset. Capture standardized photographs or video using fixed exposure, focus, camera position, and surface conditions, while recording raw files for blinded independent rating and automated image analysis. Include comparison conditions such as laser without diffraction, diffraction without laser exposure to the participant, and equivalent visual stimuli under sober conditions. Record physiological and safety-relevant variables, including heart rate, blood pressure where feasible, jaw tension, anxiety, and discomfort; the reported vasoconstriction and intense jaw clenching warrant particular caution and should not be treated as minor experimental details. Avoid escalating dose solely to achieve a higher code category, and conduct such work only within applicable ethical, legal, and medical-safety frameworks.

This analysis is generated by AI and should be considered as supplementary insight. It does not replace professional scientific review or peer evaluation.

Substances Used

4-HO-DET

30 mg
Participants
Loading participants...
Protocol Comparison
Comparison of trial parameters with the protocol
ParameterProtocolTrialVariance
Laser Wavelength650 nm650 nm+0 nm (+0.0%)
Laser Power1 mW1 mW+0.00 mW (+0.0%)
Substance Dose1000 mg30 mg-970.00 mg (-97.0%)
Projection Distance1.5 feet5 feet+3.5 feet (+233.3%)
Laser ClassClass 2Not specified-
SubstancesN,N-DMT 1000 mg4-HO-DET 30 mg-

Additional Observers:

No

Equipment Used
NameManufacturerModelSpecificationsLink
Laser Pointer--650nm-
Laser Pointer--488nm-
Diffraction Grating----

Except where otherwise noted, all content is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.